Stage III malignant mixed Müllerian tumor of the fallopian tube: A case of 5-year survival after optimal debulking and adjuvant chemotherapy with paclitaxel plus carboplatin
Main Authors: | Ching-Pei Tsai, Esther Shih-Chu Ho, Yu-Min Ke, Shih-Tien Hsu, Ren-Ching Wang, Chien-Hsing Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-06-01
|
Series: | Taiwanese Journal of Obstetrics & Gynecology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1028455912000824 |
Similar Items
-
Comparison of Efficacy and Safety Between Liposome-paclitaxel plus Carboplatin and Paclitaxel plus Carboplatin on Epithelial Ovarian Cancer
by: HOU Wenjie, et al.
Published: (2018-06-01) -
Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC
by: Katsurada N, et al.
Published: (2020-02-01) -
Uncommon Manifestations of Endocervical Malignant Mixed Mullerian Tumor with Incidental Bilateral Fallopian Tube Carcinoma
by: Kishan Prasad H L., et al.
Published: (2011-01-01) -
Malignancy of fallopian tube
by: Ranjan Agrawal
Published: (2015-01-01) -
Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysis
by: Toshinobu Hayashi, et al.
Published: (2021-01-01)